Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 21 - Number 5

Review Article (Mini-Review)

The Impacts of Non-coding RNAs and N6-Methyladenosine on Cancer: Past, Present and Future

, 21(5): 375 - 385

Zhaoyuan Xu, Guohua Ji, Ying Cui and Xiaobo Cui*


DOI: 10.2174/1568009621999210120193636



Review Article (Mini-Review)

Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma

, 21(5): 386 - 400

Geet Madhukar and Naidu Subbarao*


DOI: 10.2174/1568009620666201229120332



Review Article

The Mad2-Binding Protein p31comet as a Potential Target for Human Cancer Therapy

, 21(5): 401 - 415

Ana C. Henriques, Patrícia M. A. Silva, Bruno Sarmento and Hassan Bousbaa*


DOI: 10.2174/1568009621666210129095726




Research Article

Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues

, 21(5): 428 - 442

Karthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser and Barbara Seliger*


DOI: 10.2174/1568009620666201207145019



Research Article

Effects of Iron Chelation in Osteosarcoma

, 21(5): 443 - 455

Maura Argenziano, Alessandra Di Paola, Chiara Tortora, Daniela Di Pinto, Elvira Pota, Martina Di Martino, Silverio Perrotta, Francesca Rossi* and Francesca Punzo


DOI: 10.2174/1568009620666201230090531




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog